Benzinga
Benzinga
Benzinga
miércoles, septiembre 30

Medpace Holdings Inc

MEDPNASDAQ
Trade with Public
Trade with Public
$622.11
6.171%
al cierre: Sep 29, 5:00 PM EST
$622.11
N/A
After hour: 4:37 PM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadCompararOpcionesInforme de acciones

Medpace Holdings Analyst Price Targets

Wall Street analyst price targets and consensus rating for Medpace Holdings (MEDP).

Price Target Range — 12 Quarters

Analyst Consensus — 14 Analysts

4Buy
9Hold
1Sell
Consensus RatingHold# Analysts14Avg. Consensus PT$510Upside to Avg. PT-17.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

Ver todas las valoraciones →
DateFirmAnalystActionRating ChangePrice Target
Jul 24, 2026MizuhoAnn HynesPT RaiseOutperform$586→$665
Jul 24, 2026BMO CapitalSean DodgePT RaiseMarket Perform$400→$600
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $665

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $586 to $665.
Benzinga Newsdesk

PRO
BMO Capital Maintains Market Perform on Medpace Holdings, Raises Price Target to $600

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and raises the price target from $400 to $600.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Medpace Holdings, Raises Price Target to $609

Truist Securities analyst Jailendra Singh maintains Medpace Holdings (NASDAQ:MEDP) with a Hold and raises the price target from $462 to $609.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on Medpace Holdings, Raises Price Target to $692

RBC Capital analyst Ryan Halsted maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $484 to $692.
Benzinga Newsdesk

PRO
Baird Maintains Neutral on Medpace Holdings, Raises Price Target to $624

Baird analyst Eric Coldwell maintains Medpace Holdings (NASDAQ:MEDP) with a Neutral and raises the price target from $547 to $624.
Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Medpace Holdings, Raises Price Target to $586

Mizuho analyst Ann Hynes maintains Medpace Holdings (NASDAQ:MEDP) with a Outperform and raises the price target from $495 to $586.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved